Protocatechuic aldehyde (PCA) has been found to perform an effective neuroprotective role in MPTP or MPP+ generated PD mice (Guo et al., 2019) by correcting mitochondrial dysfunction and relieving ROS damage via the GSK3β/Nrf2 pathway. Here, GSK3B is linked to Parkinson disease.